Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update
Toxins · 21.06.2025 · 17 (7) · 314
DOI: 10.3390/toxins17070314 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 21.06.2025. Verfasst von Pedro Augusto Sampaio Rocha-Filho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuropsychiatry, Centro de Ciências Médicas, Universidade Federal de Pernambuco (UFPE), Recife CEP 50670-901, PE, Brazil. Hauptthemen laut MEDLINE: Botulinum Toxins, Headache, Facial Pain. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Botulinum toxin is a neurotoxin that is used in the treatments for several medical conditions, such as dystonia, spasticity, hemifacial spasm, overactive bladder, and hyperhidrosis. This toxin can potentially treat several pain disorders through botulinum toxin’s ability to inhibit the release of pro-nociceptive neurotransmitters into the synaptic cleft and its possible action on the central nervous system. This narrative review addresses the use of botulinum toxin in treating primary and secondary headaches and facial pain disorders. The highest level of evidence supporting its use varies among the headache and facial pain disorders: chronic migraine (multicenter, double-blind, placebo-controlled studies), trigeminal neuralgia (double-blind, placebo-controlled studies), post-traumatic headache (double-blind, placebo-controlled study), cluster headache (open-label clinical trials), nummular headache (open-label clinical trial), headache attributed to craniocervical dystonia (prospective cohort study), new daily persistent headache (retrospective cohort study), hemicrania continua, and SUNCT and SUNA (case reports). The site of toxin application and the doses used vary among the studies and depending on headache type. Botulinum toxin has been shown to be safe in different studies, with generally mild adverse reactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neuropsychiatry, Centro de Ciências Médicas, Universidade Federal de Pernambuco (UFPE), Recife CEP 50670-901, PE, Brazil.
- Headache Clinic, Hospital Universitário Oswaldo Cruz, Universidade de Pernambuco (UPE), Recife CEP 50100-130, PE, Brazil.
- Department of Neurology, Weill Cornell Medicine, New York, NY 10021, USA.
- Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA 02118, USA.
- Department of Neurology, BIDMC Comprehensive Headache Center, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
- Department of Anaesthesia, Critical Care and Pain Medicine, BIDMC Comprehensive Headache Center, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
ORCID-Profile: Pedro Augusto Sampaio Rocha-Filho, Christopher L Robinson
Zitieren
APA
Sampaio Rocha-Filho, P. A., Dominguez, M., Robinson, C. L., & Ashina, S. (2025). Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update. Toxins, 17(7), 314. https://doi.org/10.3390/toxins17070314
Vancouver
Sampaio Rocha-Filho PA, Dominguez M, Robinson CL, Ashina S. Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update. Toxins. 2025;17(7):314. doi:10.3390/toxins17070314
BibTeX
@article{SampaioRochaFilho2025,
author = {Sampaio Rocha-Filho, Pedro Augusto and Dominguez, Moises and Robinson, Christopher L and Ashina, Sait},
title = {Uses of Botulinum Toxin in Headache and Facial Pain Disorders: An Update},
journal = {Toxins},
year = {2025},
volume = {17},
number = {7},
pages = {314},
doi = {10.3390/toxins17070314}
}
EUVIMED